Acute Leukaemia
Summary
Acute leukaemia is a cancer of the blood and bone marrow where immature blood cells (blasts) multiply rapidly and crowd out normal blood cells. Think of your bone marrow as a factory that makes blood cells—in acute leukaemia, the factory starts making too many immature, non-functional cells (blasts) that can't do their job, while normal blood cells (red cells, white cells, platelets) can't be made properly. This leads to three main problems: anemia (not enough red cells—fatigue, breathlessness), infection (not enough normal white cells—fever, infections), and bleeding (not enough platelets—bruising, bleeding). There are two main types: acute myeloid leukaemia (AML—affects myeloid cells) and acute lymphoblastic leukaemia (ALL—affects lymphoid cells, more common in children). Acute leukaemia is a medical emergency that requires urgent treatment. The key to management is recognizing the condition (symptoms of anemia, infection, bleeding, sometimes organ infiltration), confirming the diagnosis (blood tests showing blasts, bone marrow biopsy), classifying the type and subtype (essential for treatment), and urgent chemotherapy (induction chemotherapy to achieve remission, then consolidation/maintenance). Early recognition and prompt treatment are essential—delayed treatment significantly increases mortality.
Key Facts
- Definition: Cancer of blood and bone marrow with rapid multiplication of immature blood cells
- Incidence: Rare (3-5 per 100,000 per year)
- Mortality: High (30-50% overall, varies by type and age)
- Peak age: Bimodal (children for ALL, older adults for AML)
- Critical feature: Anemia, infection, bleeding, blasts in blood/bone marrow
- Key investigation: Blood tests (FBC showing blasts), bone marrow biopsy
- First-line treatment: Urgent chemotherapy (induction)
Clinical Pearls
"Think of it with pancytopenia" — If a patient has pancytopenia (low red cells, white cells, platelets) with blasts in the blood, think acute leukaemia. Don't miss this.
"Fever + pancytopenia = infection until proven otherwise, but also think leukaemia" — Fever with low blood counts can be infection (neutropenic sepsis), but can also be the presenting feature of leukaemia. Check for blasts.
"Bone marrow biopsy is essential" — Blood tests may show blasts, but bone marrow biopsy is essential to confirm, classify the type, and guide treatment. Don't skip this.
"Time matters" — Acute leukaemia is a medical emergency. Once diagnosed, treatment should start urgently (usually within days). Delayed treatment increases mortality.
Why This Matters Clinically
Acute leukaemia is a life-threatening condition that requires urgent recognition and treatment. Early recognition (especially pancytopenia with blasts), prompt diagnosis (bone marrow biopsy), and urgent chemotherapy are essential. This is a condition that haematologists and oncologists manage, and prompt treatment can be life-saving.
Incidence & Prevalence
- Overall: Rare (3-5 per 100,000 per year)
- AML: More common in adults (2-3 per 100,000)
- ALL: More common in children (1-2 per 100,000)
- Trend: Stable (rare condition)
- Peak age: Bimodal (children for ALL, older adults for AML)
Demographics
| Factor | Details |
|---|---|
| Age | Bimodal (children 2-5 years for ALL, older adults 60+ years for AML) |
| Sex | Slight male predominance |
| Ethnicity | Slight variation (some populations) |
| Geography | No significant variation |
| Setting | Haematology, oncology units |
Risk Factors
Non-Modifiable:
- Age (older = higher risk for AML)
- Previous chemotherapy (higher risk)
- Genetic syndromes (higher risk)
Modifiable:
| Risk Factor | Relative Risk | Mechanism |
|---|---|---|
| Previous chemotherapy | 5-10x | Treatment-related leukaemia |
| Radiation exposure | 3-5x | Treatment-related leukaemia |
| Smoking | 2-3x | AML |
| Benzene exposure | 3-5x | AML |
Common Types
| Type | Frequency | Typical Patient |
|---|---|---|
| AML | 50-60% | Older adults |
| ALL | 30-40% | Children, young adults |
| Other | 5-10% | Various |
The Leukaemia Mechanism
Step 1: Genetic Mutation
- Mutation: Genetic mutation in blood cell precursor
- Result: Cell becomes cancerous
Step 2: Uncontrolled Growth
- Multiplication: Cancerous cells multiply rapidly
- Crowding: Crowd out normal cells in bone marrow
- Result: Normal cells can't be made
Step 3: Pancytopenia
- Anemia: Not enough red cells
- Neutropenia: Not enough normal white cells
- Thrombocytopenia: Not enough platelets
- Result: Pancytopenia
Step 4: Clinical Manifestation
- Anemia symptoms: Fatigue, breathlessness
- Infection: Fever, infections
- Bleeding: Bruising, bleeding
- Result: Clinical presentation
Step 5: Organ Infiltration (Sometimes)
- Blasts invade: Blasts can invade organs
- Organ dysfunction: Organs don't work properly
- Result: Organ-specific symptoms
Classification by Type
| Type | Definition | Clinical Features |
|---|---|---|
| AML | Myeloid cells affected | More common in adults |
| ALL | Lymphoid cells affected | More common in children |
Anatomical Considerations
Bone Marrow:
- Factory: Makes all blood cells
- Crowded: Leukaemia cells crowd out normal cells
- Result: Can't make normal cells
Organ Infiltration:
- Can invade: Any organ
- Common: Liver, spleen, lymph nodes, CNS (ALL)
- Result: Organ dysfunction
Symptoms: The Patient's Story
Typical Presentation:
History:
Signs: What You See
Vital Signs (May Be Abnormal):
| Sign | Finding | Significance |
|---|---|---|
| Temperature | May be elevated (fever, infection) | Fever, infection |
| Heart rate | May be high (anemia, fever) | Tachycardia |
| Blood pressure | Usually normal (may be low if sepsis) | Usually normal |
| Respiratory rate | May be high (anemia, infection) | Tachypnea |
General Appearance:
Examination Findings:
| Finding | What It Means | Frequency |
|---|---|---|
| Pallor | Anemia | Common |
| Bruising | Thrombocytopenia | Common |
| Petechiae | Thrombocytopenia | Common |
| Hepatosplenomegaly | Organ infiltration | 30-40% |
| Lymphadenopathy | Organ infiltration | 20-30% |
| Gum hypertrophy | Organ infiltration (AML) | 10-20% (AML) |
Signs of Complications:
Red Flags
[!CAUTION] Red Flags — Immediate Escalation Required:
- Signs of severe infection (fever, sepsis) — Medical emergency, needs urgent antibiotics
- Signs of severe bleeding — Medical emergency, needs urgent platelets, support
- Signs of severe anemia — Needs urgent blood transfusion
- Signs of hyperleukocytosis (respiratory distress, neurological symptoms) — Medical emergency, needs urgent treatment
- Signs of tumor lysis syndrome — Medical emergency, needs urgent treatment
Structured Approach: ABCDE
A - Airway
- Assessment: Usually patent
- Action: Secure if compromised
B - Breathing
- Look: May have respiratory distress (anemia, infection, hyperleukocytosis)
- Listen: May have crackles (infection)
- Measure: SpO2 (may be low)
- Action: Support if needed
C - Circulation
- Look: Signs of anemia, bleeding
- Feel: Pulse (may be fast), BP (usually normal)
- Listen: Heart sounds (may have flow murmur if anemia)
- Measure: BP (usually normal), HR (may be fast)
- Action: Monitor if severe
D - Disability
- Assessment: May have neurological symptoms (if CNS involvement or hyperleukocytosis)
- Action: Assess if severe
E - Exposure
- Look: Full examination, look for bruising, organ enlargement
- Feel: Liver, spleen, lymph nodes
- Action: Complete examination
Specific Examination Findings
Hematological Examination:
- Pallor: Anemia
- Bruising: Thrombocytopenia
- Petechiae: Thrombocytopenia
- Active bleeding: If severe
Organ Examination:
- Hepatosplenomegaly: Organ infiltration
- Lymphadenopathy: Organ infiltration
- Gum hypertrophy: Organ infiltration (AML)
- CNS: May have signs if CNS involved (ALL)
Special Tests
| Test | Technique | Positive Finding | Clinical Use |
|---|---|---|---|
| FBC | Blood test | Pancytopenia, blasts | Diagnostic |
| Bone marrow biopsy | Bone marrow sample | Blasts, confirms diagnosis | Essential |
First-Line (Bedside) - Do Immediately
1. Blood Tests (Essential)
- FBC: Shows pancytopenia, blasts
- Action: High suspicion if blasts present
2. Bone Marrow Biopsy (Essential)
- Purpose: Confirms diagnosis, classifies type
- Action: Essential for diagnosis and treatment planning
Laboratory Tests
| Test | Expected Finding | Purpose |
|---|---|---|
| Full Blood Count | Pancytopenia, blasts | Diagnostic |
| Bone marrow biopsy | Blasts, confirms type | Essential for diagnosis |
| Cytogenetics | Genetic abnormalities | Prognosis, treatment |
| Immunophenotyping | Cell markers | Classifies type |
| Coagulation | May be abnormal | Assesses bleeding risk |
Imaging
Chest X-Ray (If Respiratory Symptoms):
| Indication | Finding | Clinical Note |
|---|---|---|
| Respiratory symptoms | May show infection, mediastinal mass | If symptoms |
CT (If Organ Involvement):
| Indication | Finding | Clinical Note |
|---|---|---|
| Organ involvement | Organ enlargement, infiltration | If suspected |
Diagnostic Criteria
Clinical Diagnosis:
- Pancytopenia + blasts in blood + bone marrow showing leukaemia = Acute leukaemia
Type Classification:
- AML: Myeloid blasts
- ALL: Lymphoid blasts
Severity Assessment:
- Standard risk: Better prognosis
- High risk: Worse prognosis (based on genetics, age, etc.)
Management Algorithm
SUSPECTED ACUTE LEUKAEMIA
(Pancytopenia + blasts + symptoms)
↓
┌─────────────────────────────────────────────────┐
│ IMMEDIATE ASSESSMENT │
│ • Blood tests (FBC showing blasts) │
│ • Assess for complications (infection, bleeding) │
│ • High suspicion │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ BONE MARROW BIOPSY (ESSENTIAL) │
│ • Confirms diagnosis │
│ • Classifies type (AML vs ALL) │
│ • Cytogenetics, immunophenotyping │
│ • Essential for treatment planning │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ TREAT COMPLICATIONS (URGENT) │
│ • Infection: Antibiotics (if fever, neutropenia) │
│ • Bleeding: Platelets (if bleeding) │
│ • Anemia: Blood transfusion (if severe) │
│ • Hyperleukocytosis: Urgent treatment │
│ • Tumor lysis: Prevention, treatment │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ URGENT CHEMOTHERAPY │
├─────────────────────────────────────────────────┤
│ AML │
│ → Induction chemotherapy (usually 7+3) │
│ → Consolidation chemotherapy │
│ → May need stem cell transplant │
│ │
│ ALL │
│ → Induction chemotherapy │
│ → Consolidation, maintenance │
│ → CNS prophylaxis (ALL) │
│ → May need stem cell transplant │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ SUPPORTIVE CARE │
│ • Infection prevention, treatment │
│ • Blood product support │
│ • Monitor for complications │
└─────────────────────────────────────────────────┘
↓
┌─────────────────────────────────────────────────┐
│ MONITOR & FOLLOW-UP │
│ • Monitor response to treatment │
│ • Assess for remission │
│ • Long-term management │
└─────────────────────────────────────────────────┘
Acute/Emergency Management - The First Hour
Immediate Actions (Do Simultaneously):
-
Blood Tests (Urgent)
- FBC: Check for blasts, pancytopenia
- Action: High suspicion if blasts present
-
Assess for Complications (Urgent)
- Infection: If fever, neutropenia—urgent antibiotics
- Bleeding: If bleeding—urgent platelets
- Anemia: If severe—blood transfusion
- Action: Treat complications urgently
-
Bone Marrow Biopsy (Urgent)
- Purpose: Confirm diagnosis, classify type
- Action: Essential, don't delay
-
Haematology Consultation (Urgent)
- Urgent: Usually within 24 hours
- Action: Don't delay
-
Prepare for Chemotherapy
- Assess fitness: Assess if fit for chemotherapy
- Action: Plan treatment
Medical Management
Supportive Care (Essential):
| Intervention | Details | Notes |
|---|---|---|
| Antibiotics | If fever, neutropenia | Urgent, broad-spectrum |
| Platelets | If bleeding or very low | Prevent/treat bleeding |
| Blood transfusion | If severe anemia | Support circulation |
| Tumor lysis prevention | Allopurinol, hydration | Prevent TLS |
Chemotherapy (Essential):
| Type | Regimen | Notes |
|---|---|---|
| AML induction | Usually 7+3 (cytarabine + anthracycline) | Induction |
| ALL induction | Multi-drug regimen | Induction |
| Consolidation | As appropriate | After remission |
Disposition
Admit to Hospital:
- All cases: Need chemotherapy, monitoring
- ICU: If complications (sepsis, etc.)
Discharge Criteria:
- Not applicable initially: All need admission
- When stable: Can discharge between cycles
Follow-Up:
- Regular: Monitor response, complications
- Long-term: Ongoing management
- Remission: Monitor for relapse
Immediate (Days-Weeks)
| Complication | Incidence | Presentation | Management |
|---|---|---|---|
| Infection | 50-70% | Fever, sepsis | Antibiotics, supportive care |
| Bleeding | 30-40% | Bleeding, hemorrhage | Platelets, supportive care |
| Tumor lysis syndrome | 10-20% | Renal failure, electrolyte imbalances | Prevention, treatment |
| Death | 20-30% (if not treated) | If not treated | Prevention through early treatment |
Infection:
- Mechanism: Neutropenia
- Management: Antibiotics, supportive care
- Prevention: Infection prevention, early treatment
Early (Weeks-Months)
1. Remission (60-80%)
- Mechanism: Chemotherapy works
- Management: Continue treatment
- Prevention: Appropriate treatment
2. Relapse (20-40%)
- Mechanism: Disease returns
- Management: Re-treat, may need transplant
- Prevention: Appropriate treatment, monitoring
Late (Months-Years)
1. Cure (30-50%)
- Mechanism: Disease cured
- Management: Usually no long-term treatment needed
- Prevention: Appropriate treatment
2. Relapse or Death (50-70%)
- Mechanism: Disease not cured
- Management: Ongoing management, may need transplant
- Prevention: Appropriate treatment
Natural History (Without Treatment)
Untreated Acute Leukaemia:
- High mortality: 90-100% mortality within months
- Poor outcomes: If not treated
Outcomes with Treatment
| Variable | Outcome | Notes |
|---|---|---|
| Remission | 60-80% | Most achieve remission |
| Cure | 30-50% | Varies by type, age, genetics |
| Mortality | 20-30% | Lower with treatment |
| Relapse | 20-40% | May relapse |
Factors Affecting Outcomes:
Good Prognosis:
- Young age: Better outcomes
- Good genetics: Better outcomes
- Early treatment: Better outcomes
- Good response: Better outcomes
Poor Prognosis:
- Older age: Worse outcomes
- Poor genetics: Worse outcomes
- Delayed treatment: Worse outcomes
- Poor response: Worse outcomes
Prognostic Factors
| Factor | Impact on Prognosis | Evidence Level |
|---|---|---|
| Age | Younger = better | High |
| Genetics | Good genetics = better | High |
| Type | Some types better | High |
| Early treatment | Better outcomes | Moderate |
Key Guidelines
1. NICE Guidelines (2016) — Leukaemia: diagnosis and management. National Institute for Health and Care Excellence
Key Recommendations:
- Urgent diagnosis
- Urgent chemotherapy
- Evidence Level: 1A
Landmark Trials
Multiple studies on chemotherapy regimens, outcomes.
Evidence Strength
| Intervention | Level | Key Evidence | Clinical Recommendation |
|---|---|---|---|
| Urgent chemotherapy | 1A | Multiple studies | Essential |
| Supportive care | 1A | Multiple studies | Essential |
What is Acute Leukaemia?
Acute leukaemia is a cancer of the blood and bone marrow where immature blood cells multiply rapidly and crowd out normal blood cells. Think of your bone marrow as a factory that makes blood cells—in acute leukaemia, the factory starts making too many immature, non-functional cells that can't do their job, while normal blood cells can't be made properly.
In simple terms: Your bone marrow is making too many bad blood cells and not enough good ones. This causes anemia (not enough red cells), infection (not enough normal white cells), and bleeding (not enough platelets). This is serious and needs urgent treatment.
Why does it matter?
Acute leukaemia is a life-threatening condition that requires urgent treatment. Early recognition and prompt chemotherapy are essential. The good news? With proper treatment, many people achieve remission, and some are cured.
Think of it like this: It's like your blood cell factory making too many bad cells—it needs urgent treatment to stop this and start making good cells again.
How is it treated?
1. Diagnosis:
- Blood tests: You'll have blood tests that show abnormal cells
- Bone marrow test: You'll have a test of your bone marrow to confirm and see what type
- Why: To confirm the diagnosis and plan treatment
2. Treat Complications (Urgent):
- Infection: If you have a fever or infection, you'll get antibiotics urgently
- Bleeding: If you're bleeding, you'll get platelets to help your blood clot
- Anemia: If you're very anemic, you'll get a blood transfusion
- Why: To support your body while the leukaemia is treated
3. Chemotherapy (Urgent):
- What: You'll get strong medicines (chemotherapy) to kill the leukaemia cells
- When: Usually starts within days of diagnosis
- Why: To kill the leukaemia cells and allow your bone marrow to make normal cells again
- Duration: Usually several months of treatment
4. Supportive Care:
- Infection prevention: You'll get medicines and precautions to prevent infection
- Blood products: You'll get blood products (platelets, red cells) as needed
- Monitoring: Close monitoring for complications
The goal: Kill the leukaemia cells, allow your bone marrow to make normal cells again, and achieve remission (disease under control) or cure.
What to expect
Recovery:
- Treatment: Usually starts within days
- Hospital stay: Usually weeks to months (for chemotherapy)
- Remission: Most people achieve remission (disease under control) within weeks to months
- Cure: Some people are cured (30-50%), but this varies
After Treatment:
- Monitoring: Regular monitoring to check if the disease stays in remission
- Relapse: Some people may have a relapse (disease returns), which can be treated
- Long-term: Ongoing management, may need further treatment
Recovery Time:
- Remission: Usually within weeks to months
- Long-term: Ongoing management
When to seek help
Call 999 (or your emergency number) immediately if:
- You have a fever and feel very unwell
- You're bleeding heavily
- You feel very unwell
- You have symptoms that concern you
See your doctor if:
- You have unexplained fatigue, bruising, or infections
- You have symptoms that concern you
- You have a known diagnosis of leukaemia and develop new symptoms
Remember: If you have unexplained fatigue, bruising, or infections, especially if you have a fever, see your doctor. Acute leukaemia is serious, but with prompt treatment, many people achieve remission. Don't delay—if you're worried, seek help immediately.
Primary Guidelines
- National Institute for Health and Care Excellence. Leukaemia: diagnosis and management. NICE guideline [NG47]. 2016.
Key Trials
- Multiple studies on chemotherapy regimens, outcomes.
Further Resources
- NICE Guidelines: National Institute for Health and Care Excellence
Last Reviewed: 2025-12-25 | MedVellum Editorial Team
Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists. This information is not a substitute for professional medical advice, diagnosis, or treatment.